Home » Topics » Regulatory » Patents

Patents
RSS

Broad-spectrum antibacterial agents synthesized by Daiichi

April 2, 1998

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

New compounds synthesized at HMR upregulate LDL receptors

April 2, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Antibacterial quinolone carboxylic acids prepared at Bayer

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...